Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response to PTSC Request for Exclusion of Stockholder Proposal
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Thus, under the Rule as amended, a

shareholder proposal that would allow for shareholder use of the company’s proxy

materials to nominate director candidates, such as the proposal at issue in

AFSCME v. AIG

would be excludable. We believe the actions we are taking today will provide

certainty in the application of Rule 14a-8(i)(8) and will preserve our longstanding

interpretation of the Rule

http://www.sec.gov/rules/final/2007/34-56914.pdf

.

.

.

Be well

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply